ScienceMachine
Autonomous AI for biomedical discovery
San Francisco, California, United States
ScienceMachine develops autonomous AI agents to automate complex biomedical research workflows. The company focuses on AI agents for biomedical data analysis and research automation, leveraging a neuro-symbolic AI approach for interpretable analysis.
Only accessible to MedStartr community members.
Join nowHow We Help
Problem Statement
The complexity, inefficiency, and labor-intensiveness of current biomedical research workflows.
Core Technology
autonomous AI agents, neuro-symbolic AI
Key Differentiators
operates 24/7 and functions as a dedicated AI bioinformatician; capable of delivering output equivalent to entire data science teams
Company Info
- Business Model
- B2B SaaS
- Founded
- 2024
- Total Funding
- Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now - Website
- www.sciencemachine.ai/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Research and analytics tool used by academic institutions and biotech companies. No active clinical trials or FDA approval. Positioned as R&D acceleration rather than clinical device.
Only accessible to MedStartr community members.
Join nowWhat do you think of ScienceMachine?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now